BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 28780469)

  • 1. Role of Pannexin1 channels in the resistance of I-10 testicular cancer cells to cisplatin mediated by ATP/IP
    Wu D; Wu J; Liu H; Yu M; Tao L; Dong S; Tong X
    Biomed Pharmacother; 2017 Oct; 94():514-522. PubMed ID: 28780469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pannexin1 inhibits autophagy of cisplatin-resistant testicular cancer cells by mediating ATP release.
    Yuan M; Yao Y; Wu D; Zhu C; Dong S; Tong X
    Cell Cycle; 2022 Aug; 21(15):1651-1661. PubMed ID: 35373707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Down-regulation of pannexin 2 channel enhances cisplatin-induced apoptosis in testicular cancer I-10 cells].
    Yao Y; Dong S; Zhu C; Hu M; Du B; Tong X
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Aug; 40(8):1090-1096. PubMed ID: 32895173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro inhibited effect of gap junction composed of Cx43 in the invasion and metastasis of testicular cancer resistanced to cisplatin.
    Wu D; Li B; Liu H; Yuan M; Yu M; Tao L; Dong S; Tong X
    Biomed Pharmacother; 2018 Feb; 98():826-833. PubMed ID: 29571253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effect of Pannexin 1 channel on the invasion and migration of I-10 testicular cancer cells via ERK1/2 signaling pathway.
    Liu H; Yuan M; Yao Y; Wu D; Dong S; Tong X
    Biomed Pharmacother; 2019 Sep; 117():109090. PubMed ID: 31202174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of pannexin 1 channels in cisplatin-induced apoptosis in I-10 cells].
    Wu JF; Dong SY; Wu DD; Chen YL; Tong XH
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Nov; 36(11):1456-1460. PubMed ID: 27881333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
    Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
    Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway.
    Yao CC; Tu YR; Jiang J; Ye SF; Du HX; Zhang Y
    Oncol Rep; 2014 May; 31(5):2131-8. PubMed ID: 24627125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.
    Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J
    DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin.
    Gong X; Liu J; Zhang D; Yang D; Min Z; Wen X; Wang G; Li H; Song Y; Bai C; Li J; Zhou J
    PLoS One; 2017; 12(8):e0182410. PubMed ID: 28771580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
    Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W
    Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-31 inhibits cisplatin-induced apoptosis in non-small cell lung cancer cells by regulating the drug transporter ABCB9.
    Dong Z; Zhong Z; Yang L; Wang S; Gong Z
    Cancer Lett; 2014 Feb; 343(2):249-57. PubMed ID: 24099915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance in cisplatin-resistant ovarian carcinoma cell line.
    Du P; Zhang X; Liu H; Chen L
    DNA Cell Biol; 2015 Jul; 34(7):497-502. PubMed ID: 25941922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
    Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W
    Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. sCLU regulates cisplatin chemosensitivity of lung cancer cells in vivo.
    Ma G; Cai H; Gao L; Wang M; Wang H
    World J Surg Oncol; 2015 Feb; 13():80. PubMed ID: 25884382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H; Pu J; Zhou XL; Ning YY; Bai C
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin reverses cisplatin resistance in cisplatin-resistant lung caner cells by inhibiting FA/BRCA pathway.
    Chen P; Li J; Jiang HG; Lan T; Chen YC
    Tumour Biol; 2015 May; 36(5):3591-9. PubMed ID: 25542235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagic flux promotes cisplatin resistance in human ovarian carcinoma cells through ATP-mediated lysosomal function.
    Ma L; Xu Y; Su J; Yu H; Kang J; Li H; Li X; Xie Q; Yu C; Sun L; Li Y
    Int J Oncol; 2015 Nov; 47(5):1890-900. PubMed ID: 26397057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
    Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
    Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Hou XF; Xu LP; Song HY; Li S; Wu C; Wang JF
    World J Gastroenterol; 2017 Mar; 23(10):1796-1803. PubMed ID: 28348485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.